Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
Daniel SontupeMarket Access
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
Liz KaneImpactful Strategy
Suma Ramadas, PhDMedical Affairs
Amy GilesIncreasing Engagement
Bud BilanichSuccess Coach
Flotetuzumab demonstrated 29.4% complete response rate in evaluable primary refractory AML patientsTranslational studies suggest ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email